Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease

Hepato-Gastroenterology

Volumn 47, Issue 36, 2000, Pages 1604-1607

  Griga, T ^a   Hebler, U ^a   Voigt, E ^a   Tromm, A ^a   May, B ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Inflammatory bowel disease; Interleukin 4; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 4; VASCULOTROPIN;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOKINES; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033636694     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation
2. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
3. Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaired wound healing
4. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth
5. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid arthritis
6. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
7. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis and erythema multiforme
8. Vascular endothelial growth factor in serum of patients with inflammatory bowel disease
9. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease
10. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease
11. Vascular endothelial growth factor (VEGF) in Crohn's disease: Increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes
12. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease
13. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease
14. IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria cells from patients with inflammatory bowel disease
15. IL-4, IL-10 and IL-18 down-regulate monocytechemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells
16. Development of a Crohn's disease activity index
17. Cortisone in ulcerative colitis: Final report on a therapeutic trial
18. Gastrointestinal mucosal regeneration: Role of growth factors
19. Fibroblast growth factors modulate intestinal epithelial cell growth and migration
20. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
21. Vascular endothelial growth factor causes endothelial cell proliferation after vascular injury
22. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10
23. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease
24. Leukocyte removal filter passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: Role of bystander suppression
25. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis
26. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease
27. Role of nitric oxide in the pathogenesis of IBD
28. Increased nitric oxide synthase in ulcerative colitis
29. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: Modulation by T lymphocyte derived cytokines
30. 2+ and van Willebrand factor release in human endothelial cells
31. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
32. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages
33. Biosynthesis and metabolism of endothelium derived nitric oxide
34. Characterization of the increase in vascular permeability induced by vascular endothelial growth factor in vivo
35. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
36. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
37. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor fit-1
38. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
39. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes
40. The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium
41. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation
42. Involvement of interleukin-4 and -10 in inflammatory bowel disease
43. 4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
44. Interleukin-4 in inflammatory bowel disease and mucosal immune reactivity